About: Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.96 (-2.36%)
ABEO NASDAQ Abeona Therapeutics Inc
Abeona Therapeutics Inc share price
ABEO price activity
Último preço
$ 4,960
Variação (24h)
-0,12 USD (-2,36%)
Volume
1.62M
Volume (média 4 sem.)
-
Abertura
$ 5,04
Variação do dia
$ 4,94 - $ 5,05
Fechamento anterior
$ 5,08
Último negócio
08 Oct, 8:07 pm GMT+0
Atrasado
08 Oct, 8:07 pm GMT+0
ABEO price performance
Atrasado
08 Oct, 8:07 pm GMT+0
quote.marketSignals